Onco-nephrology: AKI in the cancer patient

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 10, 2012, Pages 1692-1700

  Lam, Albert Q ^a   Humphreys, Benjamin D ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLOPURINOL; AMPHOTERICIN B; ANGIOTENSIN RECEPTOR ANTAGONIST; BORTEZOMIB; BUSULFAN; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACLIZUMAB; DEFIBROTIDE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LENALIDOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB; TACROLIMUS; THALIDOMIDE;

ACUTE KIDNEY FAILURE; ACUTE LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COLON CANCER; CREATININE BLOOD LEVEL; DIALYSIS; ENDOMETRIUM CANCER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERCALCEMIA; HYPOVOLEMIA; KIDNEY BIOPSY; KIDNEY BLOOD FLOW; KIDNEY CANCER; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER VENOOCCLUSIVE DISEASE; LUNG NON SMALL CELL CANCER; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PATHOPHYSIOLOGY; PLASMAPHERESIS; POPULATION RESEARCH; PROGRESSION FREE SURVIVAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR LYSIS SYNDROME;

ACUTE KIDNEY INJURY; ANTINEOPLASTIC AGENTS; HUMANS; INTERDISCIPLINARY COMMUNICATION; MEDICAL ONCOLOGY; NEOPLASMS; NEPHROLOGY; PARANEOPLASTIC SYNDROMES; PATIENT CARE TEAM; PROGNOSIS; RISK FACTORS;

EID: 84867244992     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03140312     Document Type: Article

References (69)

1. Fast Stats: An Interactive Tool for Access to SEER Cancer Statistics. Surveillance Research Program, National Cancer Institute, Bethesda, MD.
2. Humphreys BD: Onco-nephrology: Kidney disease in the cancer patient: Introduction. Semin Nephrol 30: 531-533, 2010
3. Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, Sørensen HT: Incidence of acute kidney injury in cancer patients: A Danish population-based cohort study. Eur J Intern Med 22: 399-406, 2011
4. Coppin C, Kollmannsberger C, Le L, Porzsolt F, Wilt TJ: Targeted therapy for advanced renal cell cancer (RCC): A Cochrane systematic review of published randomised trials. BJU Int 108: 1556-1563, 2011
5. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA: Improved survival in multiple myeloma and the impact of novel therapies. Blood 111: 2516-2520, 2008
6. Lahoti A, Kantarjian H, Salahudeen AK, Ravandi F, Cortes JE, Faderl S, O'Brien S, Wierda W, Mattiuzzi GN: Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer 116: 4063-4068, 2010
7. Cho A, Lee JE, Kwon GY, Huh W, Lee HM, Kim YG, Kim DJ, Oh HY, Choi HY: Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy. Nephrol Dial Transplant 26: 3496-3501, 2011
8. Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P: Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study. Lancet Oncol 7: 735-740, 2006
9. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P: Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes? J Urol 181: 55-61, 2009
10. Scherr DS, Ng C, Munver R, Sosa RE, Vaughan ED Jr, Del Pizzo J: Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: Technology versus oncology. Urology 62: 1007-1011, 2003
11. Russo P, Jang TL, Pettus JA, Huang WC, Eggener SE, O'Brien MF, Karellas ME, Karanikolas NT, Kagiwada MA: Survival rates after resection for localized kidney cancer: 1989 to 2004. Cancer 113: 84-96, 2008
12. Abouassaly R, Alibhai SM, Tomlinson G, Timilshina N, Finelli A: Unintended consequences of laparoscopic surgery on partial nephrectomy for kidney cancer. J Urol 183: 467-472, 2010
13. Humphreys BD: Renal complications of hematopoietic stem cell transplantation. In: Cancer and the Kidney, edited by Cohen E, Oxford University Press, 2010, p 205-216
14. Lopes JA, Jorge S: Acute kidney injury following HCT: Incidence, risk factors and outcome. Bone Marrow Transplant 46: 1399-1408, 2011
15. Candrilli S, Bell T, Irish W, Morris E, Goldman S, Cairo MS: A comparison of inpatient length of stay and costs among patients with hematologic malignancies (excluding Hodgkin disease) associated with and without acute renal failure. Clin Lymphoma Myeloma 8: 44-51, 2008
16. Darmon M, Thiery G, Ciroldi M, Porcher R, Schlemmer B, Azoulay E: Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med 33: 765-772, 2007
17. Salahudeen AK, Kumar V, Madan N, Xiao L, Lahoti A, Samuels J, Nates J, Price K: Sustained low efficiency dialysis in the continuous mode (C-SLED): Dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol 4: 1338-1346, 2009
18. Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, Spector N: Prognosis of critically ill patients with cancer and acute renal dysfunction. J ClinOncol 24: 4003-4010, 2006
19. Perazella MA: Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents. Clin J Am Soc Nephrol 7: 1713-1721, 2012
20. Stewart AF: Clinical practice. Hypercalcemia associated with cancer. N Engl J Med 352: 373-379, 2005
21. Cohen LJ, Rennke HG, Laubach JP, Humphreys BD: The spectrum of kidney involvement in lymphoma: A case report and review of the literature. Am J Kidney Dis 56: 1191-1196, 2010
22. Richmond J, Sherman RS, Diamond HD, Craver LF: Renal lesions associated with malignant lymphomas. AmJMed 32: 184-207, 1962
23. Tornroth T, Heiro M, Marcussen N, Franssila K: Lymphomas diagnosed by percutaneous kidney biopsy. Am J Kidney Dis 42: 960-971, 2003
24. Alexanian R, Barlogie B, Dixon D: Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Arch Intern Med 150: 1693-1695, 1990
25. Bladé J, Fernández-Llama P, Bosch F, Montolíu J, Lens XM, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E: Renal failure in multiple myeloma: Presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 158: 1889-1893, 1998
26. Montseny JJ, Kleinknecht D, Meyrier A, Vanhille P, Simon P, Pruna A, Eladari D: Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant 13: 1438-1445, 1998
27. Hutchison CA, Batuman V, Behrens J, Bridoux F, Sirac C, Dispenzieri A, Herrera GA, Lachmann H, Sanders PW; International Kidney and Monoclonal Gammopathy Research Group: The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol 8: 43-51, 2012
28. Basnayake K, Cheung CK, Sheaff M, Fuggle W, Kamel D, Nakoinz S, Hutchison CA, Cook M, Stoves J, Bradwell AR, Cockwell P: Differential progression of renal scarring and determinants of late renal recovery in sustained dialysis dependent acute kidney injury secondary to myeloma kidney. J Clin Pathol 63: 884-887, 2010
29. Hutchison CA, Cockwell P, Stringer S, Bradwell A, Cook M, Gertz MA, Dispenzieri A, Winters JL, Kumar S, Rajkumar SV, Kyle RA, Leung N: Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Soc Nephrol 22: 1129-1136, 2011
30. Johnson WJ, Kyle RA, Pineda AA, O'Brien PC, Holley KE: Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 150: 863-869, 1990
31. Zucchelli P, Pasquali S, Cagnoli L, Ferrari G: Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 33: 1175-1180, 1988
32. Clark WF, Stewart AK, Rock GA, Sternbach M, Sutton DM, Barrett BJ, Heidenheim AP, Garg AX, Churchill DN; Canadian Apheresis Group: Plasma exchange when myeloma presents as acute renal failure: A randomized, controlled trial. Ann Intern Med 143: 777-784, 2005
33. Burnette BL, Leung N, Rajkumar SV: Renal improvement in myeloma with bortezomib plus plasma exchange. NEngl J Med 364: 2365-2366, 2011
34. Cagnoli L, Pasquali S, Rovinetti C, Zucchelli P: Plasma exchange therapy in acute renal failure due to multiple myeloma. Life Support Syst 1[Suppl 1]: 102-105, 1983
35. Misiani R, Remuzzi G, Bertani T, Licini R, Levoni P, Crippa A, Mecca G: Plasmapheresis in the treatment of acute renal failure in multiple myeloma. Am J Med 66: 684-688, 1979
36. Pozzi C, Pasquali S, Donini U, Casanova S, Banfi G, Tiraboschi G, Furci L, Porri MT, Ravelli M, Lupo A; Report of the Italien Renal Immunopathology Group: Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: A review of 50 cases. Clin Nephrol 28: 1-9, 1987
37. Moist L, Nesrallah G, Kortas C, Espirtu E, Ostbye T, Clark WF: Plasma exchange in rapidly progressive renal failure due to multiple myeloma. A retrospective case series. Am J Nephrol 19: 45-50, 1999
38. Gupta D, Bachegowda L, Phadke G, Boren S, Johnson D, Misra M: Role of plasmapheresis in the management of myeloma kidney: A systematic review. Hemodial Int 14: 355-363, 2010
39. Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, Hattersley J, Evans ND, Chappel MJ, Sampson P, Foggensteiner L, Adu D, Cockwell P: Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 4: 745-754, 2009
40. Peters NO, Laurain E, Cridlig J, Hulin C, Cao-Huu T, Frimat L: Impact of free light chain hemodialysis in myeloma cast nephropathy: A case-control study. Hemodial Int 15: 538-545, 2011
41. Dember LM: Light chains, casts, sheets and fibrils: Monoclonal immunoglobulin diseases and immunotactoid/fibrillary glomerulopathy. Clin J Am Soc Nephrol 1: 1320-1321, 2006
42. Ronco P, Plaisier E, Aucouturier P: Ig-related renal disease in lymphoplasmacytic disorders: An update. Semin Nephrol 30: 557-569, 2010
43. Howard SC, Jones DP, Pui CH: The tumor lysis syndrome. N Engl J Med 364: 1844-1854, 2011
44. Blum KA, Ruppert AS, Woyach JA, Jones JA, Andritsos L, Flynn JM, Rovin B, Villalona-Calero M, Ji J, Phelps M, Johnson AJ, Grever MR, Byrd JC: Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol. Leukemia 25: 1444-1451, 2011
45. Zager RA: Acute renal failure in the setting of bone marrow transplantation. Kidney Int 46: 1443-1458, 1994
46. Gruss E, Bernis C, Tomas JF, Garcia-Canton C, Figuera A, Motellón JL, Paraiso V, Traver JA, Fernandez-Rañada JM: Acute renal failure in patients following bone marrow transplantation: Prevalence, risk factors and outcome. Am J Nephrol 15: 473-479, 1995
47. Parikh CR, McSweeney PA, Korular D, Ecder T, Merouani A, Taylor J, Slat-Vasquez V, Shpall EJ, Jones RB, Bearman SI, Schrier RW: Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62: 566-573, 2002
48. Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB, Maloney DG, McSweeney P, Storb R, Sandmaier BM: Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis 45: 502-509, 2005
49. Kersting S, Koomans HA, Hené RJ, Verdonck LF: Acute renal failure after allogeneic myeloablative stem cell transplantation: Retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant 39: 359-365, 2007
50. Parikh CR, Sandmaier BM, Storb RF, Blume KG, Sahebi F, Maloney DG, Maris MB, Nieto Y, Edelstein CL, Schrier RW, McSweeney P: Acute renal failure after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol 15: 1868-1876, 2004
51. Liu H, Li YF, Liu BC, Ding JH, Chen BA, Xu WL, Qian J: A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT. Bone Marrow Transplant 45: 153-158, 2010
52. Merouani A, Shpall EJ, Jones RB, Archer PG, Schrier RW: Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int 50: 1026-1031, 1996
53. Fadia A, Casserly LF, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM: Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int 63: 1868-1873, 2003
54. Zager RA, O'Quigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM, Stewart P, Thomas ED: Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients. Am J Kidney Dis 13: 210-216, 1989
55. Parikh CR, Coca SG: Acute renal failure in hematopoietic cell transplantation. Kidney Int 69: 430-435, 2006
56. Soiffer RJ, ed: Hematopoietic Stem Cell Transplantation, Totowa, NJ, Humana, 2008
57. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 118: 255-267, 1993
58. Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, Guinan E, Vogelsang G, Krishnan A, Giralt S, Revta C, Carreau NA, Iacobelli M, Carreras E, Ruutu T, Barbui T, Antin JH, Niederwieser D: Hepatic veno-occlusive disease following stem cell transplantation: Incidence, clinical course, and outcome. Biol Blood Marrow Transplant 16: 157-168, 2010
59. Carreras E, Bertz H, Arcese W, Vernant JP, Tomás JF, Hagglund H, Bandini G, Esperou H, Russell J, de la Rubia J, Di Girolamo G, Demuynck H, Hartmann O, Clausen J, Ruutu T, Leblond V, Iriondo A, Bosi A, Ben-Bassat I, Koza V, Gratwohl A, Apperley JF; European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party: Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation. Blood 92: 3599-3604, 1998
60. McDonald GB: Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology 51: 1450-1460, 2010
61. Richardson PG, Soiffer RJ, Antin JH, Uno H, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen AR, Krishnan A, Kernan NA, Avigan DE, Spitzer TR, Shulman HM, Di Salvo DN, Revta C, Warren D, Momtaz P, Bradwin G, Wei LJ, Iacobelli M, McDonald GB, Guinan EC: Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: A multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplan 16: 1005-1017, 2010
62. George JN, Li X, McMinn JR, Terrell DR, Vesely SK, Selby GB: Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: A diagnostic dilemma. Transfusion 44: 294-304, 2004
63. Cohen EP, Hussain S, Moulder JE: Successful treatment of radiation nephropathy with angiotensin II blockade. Int J Radiat Oncol Biol Phys 55: 190-193, 2003
64. Humphreys BD, Soiffer RJ, Magee CC: Renal failure associated with cancer and its treatment: An update. J Am Soc Nephrol 16: 151-161, 2005
65. Laskin BL, Goebel J, Davies SM, Jodele S: Small vessels, big trouble in the kidneys and beyond: Hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 118: 1452-1462, 2011
66. Wolff D, Wilhelm S, Hahn J, Gentilini C, Hilgendorf I, Steiner B, Kahl C, Junghanss C, Hartung G, Casper J, Uharek L, Holler E, Freund M: Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graftversus-host disease. Bone Marrow Transplant 38: 445-451, 2006
67. Choi CM, Schmaier AH, Snell MR, Lazarus HM: Thrombotic microangiopathy in haematopoietic stem cell transplantation: Diagnosis and treatment. Drugs 69: 183-198, 2009
68. Brukamp K, Doyle AM, Bloom RD, Bunin N, Tomaszewski JE, Cizman B: Nephrotic syndrome after hematopoietic cell transplantation: Do glomerular lesions represent renal graft-versushost disease? Clin J Am Soc Nephrol 1: 685-694, 2006
69. Gondouin B, Hutchison CA: High cut-off dialysis membranes: Current uses and future potential. Adv Chronic Kidney Dis 18: 180-187, 2011